Fei Chen
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Complement system in diseases
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
Papers in
- Immunology 10
- Atherosclerosis and Cardiovascular Diseases 3
- T-cell and B-cell Immunology 2
-
- Pelvic floor disorders treatments 3
- Co-authors
- Thomas A. Wynn (1 shared paper)Joseph F. Urban (1 shared paper)Zhugong Liu (1 shared paper)Ariel Millman (1 shared paper)Nico van Rooijen (1 shared paper)Cristina T Rozo (1 shared paper)Scott A A Bowdridge (1 shared paper)William C. Gause (1 shared paper)
- Journals
- BMC Cardiovascular Disorders (3 papers)The Journal of Immunology (3 papers)Frontiers in Oncology (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fei Chen
80 papers receiving 2.5k citations
Fei Chen's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 471
- Rheumatology 147
- Parasitology 78
- Epidemiology 222
- Cancer Research 51
Countries citing papers authored by Fei Chen
This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).
Fields of papers citing papers by Fei Chen
This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection Hit paper breakdown → | 2012 | 382 |
| 2 | 2005 | 331 | |
| 3 | Knee osteoarthritis: Current status and research progress in treatment (Review) Hit paper breakdown → | 2023 | 146 |
| 4 | 2015 | 132 | |
| 5 | 1995 | 124 | |
| 6 | 2023 | 82 | |
| 7 | 2014 | 79 | |
| 8 | 2012 | 74 | |
| 9 | 2019 | 61 | |
| 10 | 2007 | 59 | |
| 11 | 2001 | 50 | |
| 12 | 2002 | 50 | |
| 13 | 2014 | 50 | |
| 14 | 1997 | 47 | |
| 15 | 2020 | 46 | |
| 16 | 2024 | 45 | |
| 17 | 2021 | 43 | |
| 18 | 2020 | 32 | |
| 19 | 2020 | 31 | |
| 20 | 1999 | 29 |
About Fei Chen
Fei Chen is a scholar working on Immunology, Rheumatology, Epidemiology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 84 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Autophagy in Disease and Therapy (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Pelvic floor disorders treatments (3 papers), Coronary Interventions and Diagnostics (3 papers), NF-κB Signaling Pathways (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (471 citations), Rheumatology (147 citations), Parasitology (78 citations), Epidemiology (222 citations) and Cancer Research (51 citations). Fei Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Thomas A. Wynn, Joseph F. Urban, Zhugong Liu, Ariel Millman, Nico van Rooijen, Cristina T Rozo, Scott A A Bowdridge, William C. Gause, Wen Hui Wu and Xianglin Shi. Their work appears in journals such as BMC Cardiovascular Disorders, The Journal of Immunology, Frontiers in Oncology, Frontiers in Cardiovascular Medicine and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.